Filing Details

Accession Number:
0001209191-20-051402
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-22 11:07:12
Reporting Period:
2020-09-18
Accepted Time:
2020-09-22 11:07:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1634379 Metacrine Inc. MTCR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219039 Keith Crandell 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
1219042 Robert Nelsen 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
1219043 Clinton Bybee 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
1605598 Arch Venture Fund Viii, L.p. 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
1616165 Arch Venture Partners Viii, Llc 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
1616176 Arch Venture Partners Viii, L.p. 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
1617237 Arch Venture Fund Viii Overage, L.p. 8755 West Higgins Road, Suite 1025
Chicago IL 60631
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-18 1,960,784 $0.00 1,960,784 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-09-18 472,251 $0.00 2,433,035 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-09-18 138,734 $0.00 2,571,769 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-09-18 210,000 $13.00 2,781,769 No 4 P Indirect See footnote
Common Stock Acquisiton 2020-09-18 138,734 $0.00 138,734 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-09-18 20,000 $13.00 158,734 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2020-09-18 1,960,784 $0.00 1,960,784 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2020-09-18 472,251 $0.00 472,251 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2020-09-18 138,734 $0.00 138,734 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2020-09-18 138,734 $0.00 138,734 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Every 5.1 shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the "Preferred Stock") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
  2. These shares are directly held by ARCH Venture Fund VIII, L.P., or ARCH Fund VIII. The sole general partner of ARCH Fund VIII is ARCHVenture Partners VIII, L.P., or ARCH Partners VIII, which may be deemed to beneficially own the shares held by ARCH Fund VIII. The solegeneral partner of ARCH Partners VIII is ARCH Venture Partners VIII, LLC, or ARCH VIII LLC, which may be deemed to beneficially own theshares held by ARCH Fund VIII. ARCH Partners VIII and ARCH VIII LLC disclaim beneficial ownership of such shares, except to the extent ofany pecuniary interest therein. The managing directors of ARCH VIII LLC are Keith L. Crandell, Clinton Bybee and Robert Nelsen, and they maybe deemed to beneficially own the shares held by ARCH Fund VIII. Messrs. Crandell, Bybee and Nelsen disclaim beneficial ownership of suchshares, except to the extent of any pecuniary interest therein.
  3. These shares are directly held by ARCH Venture Fund VIII Overage, L.P., or ARCH Fund Overage. The sole general partner of ARCH FundOverage is ARCH VIII LLC, which may be deemed to beneficially own the shares held by ARCH Fund Overage. ARCH VIII LLC disclaimsbeneficial ownership of such shares, except to the extent of any pecuniary interest therein. The managing directors of ARCH VIII LLC are KeithL. Crandell, Clinton Bybee and Robert Nelsen, and they may be deemed to beneficially own the shares held by ARCH Fund Overage. Messrs.Crandell, Bybee and Nelsen disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.